Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
R.J. Damstra, Nij Smellinghe Hosptial
ClinicalTrials.gov Identifier:
NCT01599039
First received: May 13, 2012
Last updated: September 26, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2016
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)